T0	Outcomes 0 45	Pharmacokinetics and relative bioavailability
T1	Outcomes 98 143	Pharmacokinetics and relative bioavailability
T2	Outcomes 395 412	poor metabolizer.
T3	Outcomes 538 613	pharmacokinetic parameters Cmax, AUC(0-Tlast), AUC(0-infinity) and Ae(24h).
T4	Outcomes 614 618	tmax
T5	Outcomes 674 698	relative bioavailability
T6	Outcomes 818 957	high plasma concentrations, increased AUCs and prolonged terminal half-lives as well as increased renal excretion of prajmalium bitartrate.